Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew R. Boll currently holds 811,179 shares of Imprimis Pharmaceuticals, Inc. (IMMY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew R. Boll has been a net buyer of IMMY stock. They have purchased $103.7K and sold $0 worth of shares.
Andrew R. Boll's most recent insider trade was on Dec 12, 2025, when they sold 26,665 shares at $47.06 per share.
Andrew R. Boll serves as Executive at Imprimis Pharmaceuticals, Inc. (IMMY). They have executed 26 insider transactions totaling $103.7K over their tenure at the company.
Andrew R. Boll holds the position of Executive at Imprimis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Andrew R. Boll has shown a buying trading pattern, with $103.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew R. Boll was on Jul 18, 2023, when they sold $2.5M worth of HROW shares. This transaction involved 136,350 shares at $18.23 per share.
Andrew R. Boll currently owns 811,179 shares of Imprimis Pharmaceuticals, Inc. (IMMY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew R. Boll's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew R. Boll has 26 Form 4 filings on record as an insider at Imprimis Pharmaceuticals, Inc..
Set alerts for Andrew R. Boll and 40,000+ other insiders.